Pallas Capital Advisors LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Pallas Capital Advisors LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, Holdings Channel.com reports. The fund purchased 671 shares of the biopharmaceutical company’s stock, valued at approximately $426,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes in […]
Pallas Capital Advisors LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, Holdings Channel.com reports. The fund purchased 671 shares of the biopharmaceutical company’s stock, valued at approximately $426,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes in […]
